Stifel Financial Corp Puma Biotechnology, Inc. Transaction History

Stifel Financial Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$41.2 - $59.85 $248,765 - $361,374	-6,038 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$48.3 - $68.25 $118,431 - $167,349	-2,452 Reduced 28.88%	6,038 $356,000
Q1 2018 May 11, 2018	BUY	$59.7 - $99.25 $325,484 - $541,111	5,452 Added 179.46%	8,490 $578,000
Q4 2017 Feb 14, 2018	BUY	$93.85 - $132.45 $121,441 - $171,390	1,294 Added 74.2%	3,038 $298,000
Q3 2017 Nov 13, 2017	BUY	$72.0 - $119.75 $125,568 - $208,844	1,744	1,744 $0

102

29M

60.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $138M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.